{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:03:28Z","timestamp":1787699008720,"version":"build-2784847793"},"reference-count":150,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetic nephropathy (DN) is a serious microvascular consequence of diabetes mellitus (DM), posing an encumbrance to public health worldwide. Control over the onset and progress of DN depend heavily on early detection and effective treatment. DN is a major contributor to end-stage renal disease, and a complete cure is yet to be achieved with currently available options. Though some therapeutic molecules have exhibited promise in treating DN complications, their poor solubility profile, low bioavailability, poor permeation, high therapeutic dose and associated toxicity, and low patient compliance apprehend their clinical usefulness. Recent research has indicated nano-systems as potential theranostic platforms displaying futuristic promise in the diagnosis and treatment of DN. Early and accurate diagnosis, site-specific delivery and retention by virtue of ligand conjugation, and improved pharmacokinetic profile are amongst the major advantages of nano-platforms, defining their superiority. Thus, the emergence of nanoparticles has offered fresh approaches to the possible diagnostic and therapeutic strategies regarding DN. The present review corroborates an updated overview of different types of nanocarriers regarding potential approaches for the diagnosis and therapy of DN.<\/jats:p>","DOI":"10.3389\/fendo.2023.1236686","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T10:36:07Z","timestamp":1699007767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Nanomedicines for the management of diabetic nephropathy: present progress and prospects"],"prefix":"10.3389","volume":"14","author":[{"given":"Paramita","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Chacko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarun K.","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udita","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwakarma\u00a0Vishal","family":"Phulchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj K.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh K.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Kandimalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Dewanjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.xphs.2021.05.007","article-title":"Fabrication of all-trans retinoic acid loaded chitosan\/tripolyphosphate lipid hybrid nanoparticles as a novel oral delivery approach for management of diabetic nephropathy in rats","volume":"110","author":"Asfour","year":"2021","journal-title":"J Pharm Sci"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.23736\/s0026-4806.17.05496-9","article-title":"Diabetic nephropathy in type 1 diabetes","volume":"109","author":"Papadopoulou-Marketou","year":"2018","journal-title":"Minerva Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.12861\/jrip.2015.07","article-title":"Diabetes and end-stage renal disease; a review article on new concepts","volume":"4","author":"Ghaderian","year":"2015","journal-title":"J Renal Inj Prev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.clnesp.2020.06.019","article-title":"Efficacy of probiotic supplementation in patients with diabetic nephropathy: a systematic review and meta-analysis","volume":"40","author":"AbdelQadir","year":"2020","journal-title":"Clin Nutr ESPEN."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1900\/rds.2015.12.110","article-title":"Diabetic nephropathy: new risk factors and improvements in diagnosis","volume":"12","author":"Tziomalos","year":"2015","journal-title":"Rev Diabetes Stud"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27055","article-title":"Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy","volume":"119","author":"Yaribeygi","year":"2018","journal-title":"J Cell Biochem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1590\/1806-9282.64.01.85","article-title":"Advances in early biomarkers of diabetic nephropathy","volume":"64","author":"Zhang","year":"1992","journal-title":"Rev Assoc Med Bras"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.183480","article-title":"Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum","volume":"20","author":"Chawla","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/science.1242477","article-title":"Nonadditivity of nanoparticle interactions","volume":"350","author":"Batista","year":"2015","journal-title":"Science"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S380550","article-title":"Current strategies and potential prospects for nanoparticle-mediated treatment of diabetic nephropathy","volume":"15","author":"Liu","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B11","doi-asserted-by":"publisher","first-page":"102487","DOI":"10.1016\/j.jddst.2021.102487","article-title":"Nanotechnology based drug delivery system: Current strategies and emerging therapeutic potential for medical science","volume":"63","author":"Sahu","year":"2021","journal-title":"J Drug Delivery Sci Technol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejphar.2016.08.022","article-title":"Mechanistic insight of diabetic nephropathy and its pharmacotherapeutic targets: an update","volume":"791","author":"Bhattacharjee","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-4939-9841-8_1","article-title":"Diabetic nephropathy: an overview","volume":"2067","author":"Sagoo","year":"2020","journal-title":"Methods Mol Biol"},{"key":"B14","unstructured":"International Diabetes Federation Diabetes Atlas2022"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.1016\/j.nephro.2018.02.007","article-title":"Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives","author":"Rossing","year":"2018","journal-title":"Nephrol Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2020-0335","article-title":"Nanomedicine in the treatment of diabetic nephropathy","volume":"13","author":"Desai","year":"2021","journal-title":"Future Med Chem"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26020258","article-title":"Myricitrin, a Glycosyloxyflavone in Myrica esculenta Bark Ameliorates Diabetic Nephropathy via Improving Glycemic Status, Reducing Oxidative Stress, and Suppressing Inflammation","volume":"26","author":"Dua","year":"2021","journal-title":"Molecules"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21113798","article-title":"Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy","volume":"21","author":"Rayego-Mateos","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-022-00559-y","article-title":"Glomerular hyperfiltration","volume":"18","author":"Cortinovis","year":"2022","journal-title":"Nat Rev Nephrol."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-13009-0_9","article-title":"Mechanisms of diabetic nephropathy in humans and experimental animals","author":"Khoury","year":"2023","journal-title":"Blood Pressure Disord Diabetes Mellitus"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.07.112","article-title":"Taraxerol, a pentacyclic triterpenoid, from Abroma augusta leaf attenuates diabetic nephropathy in type 2 diabetic rats","volume":"94","author":"Khanra","year":"2017","journal-title":"BioMed Pharmacother"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2174\/1871530321666211119144309","article-title":"Role of polyphenol in regulating oxidative stress, inflammation, fibrosis, and apoptosis in diabetic nephropathy","volume":"22","author":"Sapian","year":"2022","journal-title":"Endocr Metab Immune Disord Drug Targets."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33235","article-title":"A narrative review of new treatment options for diabetic nephropathy","volume":"15","author":"Pillai","year":"2023","journal-title":"Cureus"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00172","article-title":"Dynamic phenotypes and molecular mechanisms to understand the pathogenesis of diabetic nephropathy in two widely used animal models of type 2 diabetes mellitus","volume":"8","author":"Liu","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1681\/asn.2014090853","article-title":"Store-operated ca2+ Channels in mesangial cells inhibit matrix protein expression","volume":"26","author":"Wu","year":"2015","journal-title":"J Am Soc Nephrol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrd4477","article-title":"Managing diabetes with nanomedicine: challenges and opportunities","volume":"14","author":"Veiseh","year":"2015","journal-title":"Nat Rev Drug Discov"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/chemosensors8040117","article-title":"Nanomaterials for diagnosis and treatment of brain cancer: Recent updates","volume":"8","author":"Mukhtar","year":"2020","journal-title":"Chemosensors"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2022.103409","article-title":"Recent advances in flavonoid-based nanocarriers as an emerging drug delivery approach for cancer chemotherapy","volume":"28","author":"Dewanjee","year":"2023","journal-title":"Drug Discovery Today"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062217","article-title":"Plant-based antidiabetic nanoformulations: the emerging paradigm for effective therapy","volume":"21","author":"Dewanjee","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-019-2531-7","article-title":"The effects of a hirudin\/liposome complex on a diabetic nephropathy rat model","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Complement Altern Med"},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-08-100557-6.00009-2","article-title":"Pharmacokinetics and biodistribution of the nanoparticles","volume-title":"Advances in nanomedicine for the delivery of therapeutic nucleic acids","author":"Raza","year":"2017"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.3390\/app11167187","article-title":"Nanotechnology, nanomedicine, and the kidney","volume":"11","author":"Hauser","year":"2021","journal-title":"Appl Sci"},{"key":"B34","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/cancers11050640","article-title":"Active targeting strategies using biological ligands for nanoparticle drug delivery systems","volume":"11","author":"Yoo","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.3390\/ph15121494","article-title":"Renal proximal tubular cells: A new site for targeted delivery therapy of diabetic kidney disease","volume":"15","author":"Li","year":"2022","journal-title":"Pharm (Basel)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1200718109","article-title":"Polycation-siRNA nanoparticles can disassemble at the kidney glomerular basement membrane","volume":"109","author":"Zuckerman","year":"2012","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.5b05066","article-title":"Short- and long-term tracking of anionic ultrasmall nanoparticles in kidney","volume":"10","author":"Liang","year":"2016","journal-title":"ACS Nano."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.01.008","article-title":"Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities","volume":"25","author":"Raval","year":"2020","journal-title":"Drug Discovery Today"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0913667107","article-title":"Paradoxical glomerular filtration of carbon nanotubes","volume":"107","author":"Ruggiero","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3390\/ijms22052557","article-title":"Targeted Delivery of Soluble Guanylate Cyclase (sGC) Activator Cinaciguat to Renal Mesangial Cells via Virus-Mimetic Nanoparticles Potentiates Anti-Fibrotic Effects by cGMP-Mediated Suppression of the TGF-\u03b2 Pathway","volume":"22","author":"Fleischmann","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2003.11.017","article-title":"Poly(vinylpyrrolidone-co-dimethyl maleic acid) as a novel renal targeting carrier","volume":"95","author":"Yamamoto","year":"2004","journal-title":"J Controlled Release"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s111284","article-title":"Renal targeting potential of a polymeric drug carrier, poly-l-glutamic acid, in normal and diabetic rats","volume":"12","author":"Chai","year":"2017","journal-title":"Int J Nanomed"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2013.09.013","article-title":"Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles","volume":"172","author":"Ernsting","year":"2013","journal-title":"J Control Release"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1021\/mp800051m","article-title":"Factors affecting the clearance and biodistribution of polymeric nanoparticles","volume":"5","author":"Alexis","year":"2008","journal-title":"Mol Pharm"},{"key":"B45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12951-021-00917-1","article-title":"Calycosin-loaded nanoliposomes as potential nanoplatforms for treatment of diabetic nephropathy through regulation of mitochondrial respiratory function","volume":"19","author":"Huang","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2020.05.002","article-title":"A review of the application of nanoparticles in the diagnosis and treatment of chronic kidney disease","volume":"5","author":"Ma","year":"2020","journal-title":"Bioact Mater"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.7150\/ntno.78102","article-title":"Development and in vivo pharmacokinetic and pharmacodynamic evaluation of an oral innovative cyclodextrin complexed lipid nanoparticles of irbesartan formulation for enhanced bioavailability","volume":"7","author":"Dudhipala","year":"2023","journal-title":"Nanotheranostics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-52390-4","article-title":"Method and its composition for encapsulation, stabilization, and delivery of siRNA in anionic polymeric nanoplex: An in vitro-in vivo assessment","volume":"9","author":"Raval","year":"2019","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/ma12040617","article-title":"Superparamagnetic iron oxide nanoparticles-current and prospective medical applications","volume":"12","author":"Duli\u0144ska-Litewka","year":"2019","journal-title":"Materials (Basel)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s11671-016-1714-0","article-title":"Biogenic fabrication of iron\/iron oxide nanoparticles and their application","volume":"11","author":"Siddiqi","year":"2016","journal-title":"Nanoscale Res Lett"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11307-015-0829-5","article-title":"LOX-1-targeted iron oxide nanoparticles detect early diabetic nephropathy in db\/db mice","volume":"17","author":"Luo","year":"2015","journal-title":"Mol Imaging Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2009.03.057","article-title":"Potential dependent superiority of gold nanoparticles in comparison to iodinated contrast agents","volume":"75","author":"Jackson","year":"2010","journal-title":"Eur J Radiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"865283","DOI":"10.1155\/2013\/865283","article-title":"Evaluation of the X-ray absorption by gold nanoparticles solutions","volume":"2013","author":"K\u00fcnzel","year":"2013","journal-title":"Int Scholarly Res Notices."},{"key":"B54","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/j.jconrel.2022.08.047","article-title":"Quantum dots: The cutting-edge nanotheranostics in brain cancer management","volume":"350","author":"Chakraborty","year":"2022","journal-title":"J Control Release"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S81395","article-title":"Dual-color immunofluorescent labeling with quantum dots of the diabetes-associated proteins aldose reductase and Toll-like receptor 4 in the kidneys of diabetic rats","volume":"10","author":"Liu","year":"2015","journal-title":"Int J Nanomed"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10967-017-5520-7","article-title":"Production of 89Sr-doped CdSe QDs@ PAMAM as the radioanalytical-fluorescent indicator of renal injury and the preliminary application in diabetic nephropathy model","volume":"314","author":"Liu","year":"2017","journal-title":"J Radioanalytical Nucl Chem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.06.017","article-title":"MicroRNA: A new generation therapeutic target in diabetic nephropathy","volume":"155","author":"Dewanjee","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.3390\/jcm11185271","article-title":"Urinary exosomal microRNAs as biomarkers for obesity-associated chronic kidney disease","volume":"11","author":"Earle","year":"2022","journal-title":"J Clin Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2020.113967","article-title":"Determination of certain urinary microRNAs as promising biomarkers in diabetic nephropathy patients using gold nanoparticles","volume":"609","author":"Nossier","year":"2020","journal-title":"Anal Biochem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s13205-020-02405-z","article-title":"An optimal method for measuring biomarkers: colorimetric optical image processing for determination of creatinine concentration using silver nanoparticles","volume":"10","author":"Narimani","year":"2020","journal-title":"3 Biotech."},{"key":"B61","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/s23010344","article-title":"Gold nanoparticles\/nanographene-based 3D sensors integrated in mini-platforms for thiamine detection","volume":"23","author":"Gheorghe","year":"2022","journal-title":"Sensors (Basel)"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1021\/mp4001124","article-title":"Anti-VCAM-1 and anti-E-selectin SAINT-O-Somes for selective delivery of siRNA into inflammation-activated primary endothelial cells","volume":"10","author":"Kowalski","year":"2013","journal-title":"Mol Pharm"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138870","article-title":"Targeting rapamycin to podocytes using a vascular cell adhesion molecule-1 (VCAM-1)-harnessed SAINT-based lipid carrier system","volume":"10","author":"Visweswaran","year":"2015","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.06.070","article-title":"Combination of coenzyme Q10-loaded liposomes with ultrasound targeted microbubbles destruction (UTMD) for early theranostics of diabetic nephropathy","volume":"528","author":"Yue","year":"2017","journal-title":"Int J Pharm"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2017.10.012","article-title":"Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats","volume":"111","author":"Ahad","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1080\/21691401.2018.1457538","article-title":"Intrarenal delivery of bFGF-loaded liposome under guiding of ultrasound-targeted microbubble destruction prevent diabetic nephropathy through inhibition of inflammation","volume":"46","author":"Sheng","year":"2018","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.7150\/thno.37538","article-title":"Kidney-targeted rhein-loaded liponanoparticles for diabetic nephropathy therapy via size control and enhancement of renal cellular uptake","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2020.09.005","article-title":"Kidney-targeted astaxanthin natural antioxidant nanosystem for diabetic nephropathy therapy","volume":"156","author":"Chen","year":"2020","journal-title":"Eur J Pharmaceutics Biopharmaceutics."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1038\/s41598-020-59411-7","article-title":"Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats","volume":"10","author":"Tang","year":"2020","journal-title":"Sci Rep"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119197","article-title":"Silymarin nanoliposomes attenuate renal injury on diabetic nephropathy rats via co-suppressing TGF-\u03b2\/Smad and JAK2\/STAT3\/SOCS1 pathway","volume":"271","author":"Chen","year":"2021","journal-title":"Life Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.22038\/ijbms.2019.13989","article-title":"Antioxidant, anti-apoptotic, and protective effects of myricitrin and its solid lipid nanoparticle on streptozotocin-nicotinamide-induced diabetic nephropathy in type 2 diabetic male mice","volume":"22","author":"Ahangarpour","year":"2019","journal-title":"Iran J Basic Med Sci"},{"key":"B72","doi-asserted-by":"publisher","first-page":"731","DOI":"10.22038\/ijbms.2023.71189.15462","article-title":"Anti-oxidant, anti-apoptotic, and protective effects of myricitrin and its solid lipid nanoparticle on streptozotocin-nicotinamide induced diabetic nephropathy in type 2 diabetic male mice","volume":"26","author":"Mohebbati","year":"2023","journal-title":"Iranian J basic Med Sci"},{"key":"B73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1208\/s12249-019-1597-3","article-title":"Preparation of ergosterol-loaded nanostructured lipid carriers for enhancing oral bioavailability and antidiabetic nephropathy effects","volume":"21","author":"Dong","year":"2020","journal-title":"AAPS PharmSciTech."},{"key":"B74","doi-asserted-by":"publisher","first-page":"101328","DOI":"10.1016\/j.jddst.2019.101328","article-title":"Preparation, optimization and biological evaluation of gymnemic acid loaded niosomes against streptozotocin-nicotinamide induced diabetic-nephropathy in Wistar rats","volume":"54","author":"Singhal","year":"2019","journal-title":"J Drug Delivery Sci Technol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-021-00971-0","article-title":"Ameliorative effect of rubiadin-loaded nanocarriers in STZ-NA-induced diabetic nephropathy in rats: formulation optimization, molecular docking, and in vivo biological evaluation","volume":"12","author":"Tinku","year":"2022","journal-title":"Drug Delivery Transl Res"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.7150\/thno.7866","article-title":"Megalin-mediated specific uptake of chitosan\/siRNA nanoparticles in mouse kidney proximal tubule epithelial cells enables AQP1 gene silencing","volume":"4","author":"Gao","year":"2014","journal-title":"Theranostics"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2013.06.019","article-title":"Pluronic P85\/poly(lactic acid) vesicles as novel carrier for oral insulin delivery","volume":"111","author":"Xiong","year":"2013","journal-title":"Colloids Surf B Biointerfaces."},{"key":"B78","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/nat.2014.0505","article-title":"siRNA delivery to the glomerular mesangium using polycationic cyclodextrin nanoparticles containing siRNA","volume":"25","author":"Zuckerman","year":"2015","journal-title":"Nucleic Acid Ther"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S146978","article-title":"Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium","volume":"12","author":"Tong","year":"2017","journal-title":"Int J Nanomed"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2017.03.024","article-title":"Megalin-targeted enhanced transfection efficiency in cultured human HK-2 renal tubular proximal cells using aminoglycoside-carboxyalkyl- polyethylenimine -containing nanoplexes","volume":"523","author":"Oroojalian","year":"2017","journal-title":"Int J Pharm"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S166445","article-title":"Kidney-targeted drug delivery via rhein-loaded polyethyleneglycol-co-polycaprolactone-co-polyethylenimine nanoparticles for diabetic nephropathy therapy","volume":"13","author":"Chen","year":"2018","journal-title":"Int J Nanomed"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2017.1371644","article-title":"Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension","volume":"36","author":"Kecel-G\u00fcnd\u00fcz","year":"2018","journal-title":"J Biomol Struct Dyn."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s12291-018-0771-9","article-title":"Study of insulin-loaded chitosan nanoparticle effects on TGF-\u03b21 and fibronectin expression in kidney tissue of type 1 diabetic rats","volume":"34","author":"Ghavimishamekh","year":"2019","journal-title":"Indian J Clin Biochem"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1080\/10717544.2019.1642417","article-title":"Design and optimization of crocetin loaded PLGA nanoparticles against diabetic nephropathy via suppression of inflammatory biomarkers: a formulation approach to preclinical study","volume":"26","author":"Yang","year":"2019","journal-title":"Drug Deliv."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-020-00699-7","article-title":"Polydatin-loaded chitosan nanoparticles ameliorates early diabetic nephropathy by attenuating oxidative stress and inflammatory responses in streptozotocin-induced diabetic rat","volume":"19","author":"Abd El-Hameed","year":"2020","journal-title":"J Diabetes Metab Disord"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1049\/nbt2.12030","article-title":"Nephroprotective role of nanoencapsulated Tinospora cordifolia (Willd.) using polylactic acid nanoparticles in streptozotocin-induced diabetic nephropathy rats","volume":"15","author":"Ambalavanan","year":"2021","journal-title":"IET Nanobiotechnol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118112","article-title":"Brij-functionalized chitosan nanocarrier system enhances the intestinal permeability of P-glycoprotein substrate-like drugs","volume":"266","author":"Xiong","year":"2021","journal-title":"Carbohydr Polym."},{"key":"B88","doi-asserted-by":"publisher","first-page":"100181","DOI":"10.1016\/j.mtbio.2021.100181","article-title":"Novel glucose-responsive nanoparticles based on p-hydroxyphenethyl anisate and 3-acrylamidophenylboronic acid reduce blood glucose and ameliorate diabetic nephropathy","volume":"13","author":"Ma","year":"2022","journal-title":"Materials Today Bio."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.S176013","article-title":"Amelioration of diabetic nephropathy using pomegranate peel extract-stabilized gold nanoparticles: assessment of NF-\u03baB and Nrf2 signaling system","volume":"14","author":"Manna","year":"2019","journal-title":"Int J Nanomed"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.4314\/njb.v37i2.12","article-title":"Effects of momordica charantia silver nanoparticles on the expressions of genes associated with lipid metabolism and nephrotoxicity in streptozotocin-induced rats","volume":"37","author":"Elekofehinti","year":"2020","journal-title":"Nigerian J Biotechnol"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s40200-021-00739-w","article-title":"Momordica charantia silver nanoparticles modulate SOCS\/JAK\/STAT and P13K\/Akt\/PTEN signalling pathways in the kidney of streptozotocin-induced diabetic rats","volume":"20","author":"Elekofehinti","year":"2021","journal-title":"J Diabetes Metab Disord"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2022.04.200","article-title":"Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery","volume":"209","author":"Asal","year":"2022","journal-title":"Int J Biol Macromol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1039\/D0NR06098D","article-title":"A ROS-scavenging multifunctional nanoparticle for combinational therapy of diabetic nephropathy","volume":"12","author":"Tong","year":"2020","journal-title":"Nanoscale"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.110.176222","article-title":"Single application of low-dose mycophenolate mofetil-OX7-immunoliposomes ameliorates experimental mesangial proliferative glomerulonephritis","volume":"337","author":"Suana","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"B95","doi-asserted-by":"publisher","first-page":"86","DOI":"10.18203\/issn.2454-2156.IntJSciRep20161466","article-title":"Impact of nanoparticle albumin-bound paclitaxel on microscopic structure and immunohistochemical expression of transforming growth factor-\u03b21 in the renal cortex of rat diabetic nephropathy","volume":"2","author":"Mazroa","year":"2016","journal-title":"Int J"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2015.06.012","article-title":"Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin","volume":"94","author":"Yuan","year":"2015","journal-title":"Eur J Pharm Biopharm."},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2017.2902","article-title":"Albumin-based nanoparticles as methylprednisolone carriers for targeted delivery towards the neonatal Fc receptor in glomerular podocytes","volume":"39","author":"Wu","year":"2017","journal-title":"Int J Mol Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"100458","DOI":"10.1016\/j.colcom.2021.100458","article-title":"Effect of neutrophil-like melanin biomimic photothermal nanoparticles on glomerular mesangial cells in rats with gestational diabetic nephropathy","volume":"43","author":"Li","year":"2021","journal-title":"Colloid Interface Sci Commun"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201200733","article-title":"Kidney podocytes as specific targets for cyclo(RGDfC)-modified nanoparticles","volume":"8","author":"Pollinger","year":"2012","journal-title":"Small"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2022.2069966","article-title":"The therapeutic prospect of zinc oxide nanoparticles in experimentally induced diabetic nephropathy","volume":"11","author":"Abd El-Baset","year":"2023","journal-title":"Tissue barriers."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23430","article-title":"Promising renoprotective effect of gold nanoparticles and dapagliflozin in diabetic nephropathy via targeting miR-192 and miR-21","volume":"37","author":"Al-Tantawy","year":"2023","journal-title":"J Biochem Mol toxicol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/1061186x.2022.2106488","article-title":"Poly-\u03b3-glutamic acid coating polymeric nanoparticles enhance renal drug distribution and cellular uptake for diabetic nephropathy therapy","volume":"31","author":"Wang","year":"2023","journal-title":"J Drug targeting."},{"key":"B103","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3390\/metabo13030400","article-title":"Effect of Selenium Nanoparticles and\/or Bee Venom against STZ-Induced Diabetic Cardiomyopathy and Nephropathy","volume":"13","author":"Lotfy","year":"2023","journal-title":"Metabolites"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.2174\/1389201023666220822112923","article-title":"In vitro antioxidant, anti-inflammatory, antimicrobial, and antidiabetic activities of synthesized chitosan-loaded p-coumaric acid nanoparticles","volume":"24","author":"Venkatesan","year":"2023","journal-title":"Curr Pharm Biotechnol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2021.103007","article-title":"Antidiabetic nephropathy effects of synthesized gold nanoparticles through mitigation of oxidative stress","volume":"14","author":"Yu","year":"2021","journal-title":"Arabian J Chem"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1039\/d1nr02065j","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.24363","article-title":"CoQ10-loaded liposomes combined with UTMD prevented early nephropathy of diabetic rats","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abd1471","article-title":"Targeted knockdown of Kv1.3 channels in T lymphocytes corrects the disease manifestations associated with systemic lupus erythematosus","volume":"6","author":"Khodoun","year":"2020","journal-title":"Sci Adv"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101409","article-title":"Study of the target effect of mannose modified liposomes on diabetic rat kidney based on GLUT","volume":"55","author":"Yang","year":"2020","journal-title":"J Drug Delivery Sci Technol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1080\/08982104.2020.1780607","article-title":"Effect of glutathione liposomes on diabetic nephropathy based on oxidative stress and polyol pathway mechanism","volume":"31","author":"Shen","year":"2021","journal-title":"J Liposome Res"},{"key":"B111","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3390\/pharmaceutics11020055","article-title":"Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery","volume":"11","author":"Ge","year":"2019","journal-title":"Pharmaceutics"},{"key":"B112","doi-asserted-by":"publisher","first-page":"121878","DOI":"10.1016\/j.ijpharm.2022.121878","article-title":"A state-of-the-art review on the recent advances of niosomes as a targeted drug delivery system","volume":"624","author":"Yasamineh","year":"2022","journal-title":"Int J Pharmaceutics"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120876","article-title":"Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer","volume":"307","author":"Dutta","year":"2022","journal-title":"Life Sci"},{"key":"B114","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-12-821712-2.00012-8","article-title":"Smart multifunctional nanosystem: Next-generation drug delivery platform for drug-resistant breast cancer","volume-title":"Multifunctional Theranostic Nanomedicines in Cancer","author":"Paul","year":"2021"},{"key":"B115","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/hypertensionaha.117.09843","article-title":"Selective nanoparticle targeting of the renal tubules","volume":"71","author":"Williams","year":"2018","journal-title":"Hypertension"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3109\/1061186x.2010.521158","article-title":"Enhanced accumulation of low-molecular-weight chitosan in kidneys: a study on the influence of N-acetylation of chitosan on the renal targeting","volume":"19","author":"Yuan","year":"2011","journal-title":"J Drug Targeting"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-019-00675-6","article-title":"Gold nanoparticles attenuate albuminuria by inhibiting podocyte injury in a rat model of diabetic nephropathy","volume":"10","author":"Alomari","year":"2020","journal-title":"Drug Delivery Transl Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2014.09.017","article-title":"Selenium nanoparticles involve HSP-70 and SIRT1 in preventing the progression of type 1 diabetic nephropathy","volume":"223","author":"Kumar","year":"2014","journal-title":"Chem Biol Interact"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.21608\/ajnsa.2020.19809.1300","article-title":"Preparation and characterization of chitosan-stabilized selenium nanoparticles for ameliorating experimentally induced diabetic nephropathy in rats","volume":"53","author":"Khater","year":"2020","journal-title":"Arab J Nucl Sci Applications."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119674","article-title":"Stabilized-chitosan selenium nanoparticles efficiently reduce renal tissue injury and regulate the expression pattern of aldose reductase in the diabetic-nephropathy rat model","volume":"279","author":"Khater","year":"2021","journal-title":"Life Sci"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-021-15905-z","article-title":"Supplementation with selenium nanoparticles alleviates diabetic nephropathy during pregnancy in the diabetic female rats","volume":"29","author":"Alhazza","year":"2022","journal-title":"Environ Sci Pollut Res Int"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.arabjc.2022.103761","article-title":"Nephroprotective properties of chitosan\/sodium lignosulfonate\/Au nanoparticles in streptozotocin-induced nephropathy in mice: Introducing a novel therapeutic drug for the treatment of nephropathy","volume":"15","author":"Gong","year":"2022","journal-title":"Arabian J Chem"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1049\/nbt2.12026","article-title":"Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin-induced type 1 diabetes in rats","volume":"15","author":"Alomari","year":"2021","journal-title":"IET Nanobiotechnol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s12011-021-02773-4","article-title":"The prospective ameliorative role of zinc oxide nanoparticles in STZ-induced diabetic nephropathy in rats: mechanistic targeting of autophagy and regulating nrf2\/TXNIP\/NLRP3 inflammasome signaling","volume":"200","author":"Abd El-Khalik","year":"2022","journal-title":"Biol Trace Elem Res"},{"key":"B125","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/s42003-021-02546-8","article-title":"Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice","volume":"4","author":"Adhikari","year":"2021","journal-title":"Commun Biol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201805730","article-title":"Degradability and clearance of inorganic nanoparticles for biomedical applications","volume":"31","author":"Yang","year":"2019","journal-title":"Advanced materials (Deerfield Beach Fla)."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2022.09.021","article-title":"Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney","volume":"22","author":"Chen","year":"2023","journal-title":"Bioact Mater"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1021\/acsanm.1c00335","article-title":"Water-soluble noble metal nanoparticle catalysts capped with small organic molecules for organic transformations in water","volume":"4","author":"Alam","year":"2021","journal-title":"ACS Appl Nano Materials."},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2020.06.024","article-title":"Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications","volume":"156","author":"Chung","year":"2020","journal-title":"Adv Drug Delivery Rev"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S2.4.715","article-title":"Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo","volume":"2","author":"Kaiser","year":"2007","journal-title":"Int J Nanomed"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1021\/ja075937f","article-title":"Plasma clearance of bacteriophage Qbeta particles as a function of surface charge","volume":"130","author":"Prasuhn","year":"2008","journal-title":"J Am Chem Society."},{"key":"B132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jconrel.2007.04.003","article-title":"Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo","volume":"120","author":"Singh","year":"2007","journal-title":"J Control Release"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2010.04.005","article-title":"Viral nanoparticles as platforms for next-generation therapeutics and imaging devices","volume":"6","author":"Steinmetz","year":"2010","journal-title":"Nanomed Nanotechnol Biology Med"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1021\/nl504610d","article-title":"Mesoscale nanoparticles selectively target the renal proximal tubule epithelium","volume":"15","author":"Williams","year":"2015","journal-title":"Nano Lett"},{"key":"B135","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41467-017-00834-8","article-title":"Targeted delivery of celastrol to mesangial cells is effective against mesangioproliferative glomerulonephritis","volume":"8","author":"Guo","year":"2017","journal-title":"Nat Commun"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12123622","article-title":"Epigenetics in breast cancer therapy\u2014new strategies and future nanomedicine perspectives","volume":"12","author":"Buocikova","year":"2020","journal-title":"Cancers (Basel)."},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2010.08.011","article-title":"Mesangial pathology in glomerular disease: targets for therapeutic intervention","volume":"62","author":"ScIndia","year":"2010","journal-title":"Advanced Drug Delivery Rev"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02061-1","article-title":"The landscape of mRNA nanomedicine","volume":"28","author":"Huang","year":"2022","journal-title":"Nat Med"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: A review","volume":"322","author":"Chen","year":"2019","journal-title":"Jama"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1186\/1743-8977-7-20","article-title":"Subchronic oral toxicity of silver nanoparticles","volume":"7","author":"Kim","year":"2010","journal-title":"Particle Fibre Toxicol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1021\/nn302649p","article-title":"Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure","volume":"6","author":"van der Zande","year":"2012","journal-title":"ACS Nano."},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3109\/17435390.2015.1072588","article-title":"Effects of particle size and coating on toxicologic parameters, fecal elimination kinetics and tissue distribution of acutely ingested silver nanoparticles in a mouse model","volume":"10","author":"Bergin","year":"2016","journal-title":"Nanotoxicology"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2016.04.010","article-title":"Oral subchronic exposure to silver nanoparticles in rats","volume":"92","author":"Garcia","year":"2016","journal-title":"Food Chem Toxicol"},{"key":"B144","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3109\/15376516.2010.529184","article-title":"Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats","volume":"21","author":"Tiwari","year":"2011","journal-title":"Toxicol Mech Methods"},{"key":"B145","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.3390\/ijms21072375","article-title":"Health impact of silver nanoparticles: A review of the biodistribution and toxicity following various routes of exposure","volume":"21","author":"Ferdous","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00008.2018","article-title":"Learning physiology from inherited kidney disorders","volume":"99","author":"van der Wijst","year":"2019","journal-title":"Physiol Rev"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0403-3","article-title":"The health effects of ultrafine particles","volume":"52","author":"Schraufnagel","year":"2020","journal-title":"Exp Mol Med"},{"key":"B148","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.lfs.2015.04.018","article-title":"Extracellular superoxide dismutase ameliorates streptozotocin-induced rat diabetic nephropathy via inhibiting the ROS\/ERK1\/2 signaling","volume":"135","author":"Kuo","year":"2015","journal-title":"Life Sci"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2019.02.014","article-title":"Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo- controlled clinical trial","volume":"43","author":"Asadi","year":"2019","journal-title":"Complementary therapies Med"},{"key":"B150","article-title":"The effect of nano-curcumin on HbA1c, fasting blood glucose, and lipid profile in diabetic subjects: a randomized clinical trial","volume":"6","author":"Rahimi","year":"2016","journal-title":"Avicenna J phytomedicine."}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1236686\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T10:36:17Z","timestamp":1699007777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1236686\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":150,"alternative-id":["10.3389\/fendo.2023.1236686"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1236686","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"article-number":"1236686"}}